CureVac NV (MIL:1CVAC)
€ 2.944 0.144 (5.14%) Market Cap: 682.36 Mil Enterprise Value: 167.57 Mil PE Ratio: 5.46 PB Ratio: 0.85 GF Score: 41/100

Q3 2024 CureVac NV Earnings Call Transcript

Nov 12, 2024 / 02:00PM GMT
Release Date Price: €2.6 (-0.99%)
Sarah Fakih
CureVac NV - Vice President - Corporate Communications and Investor Relations

Financial Officer after Michael.

Have you seen the first, last week and I join into revolution?

Believe it or Senior Micro Finance will be available for QA question.

Please note that this policy will cross and is not high on the United Presentation section under Investor Relations on all websites.

Before we begin to forward, this is the discussions and responses to your questions on this call reflect you as of today. Tuesday 1,112, 2024.

When will we make these statements and providing responses to your questions that state our intentions, beliefs, expectations or predictions of pretention?

These constitute forward-looking statements for the purpose of the state harmon provision.

These statements involve risks and uncertainties that could cause actual results to different material materially from those projections.

Do you have any sense or obligation to revise any form of a statement?

For more information? Please refer to our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot